In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...
MedPage Today on MSN3d
Rapid Improvement in Atopic Dermatitis With Dual JAK/TYK2 InhibitorMore than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 weeks of ...
GMA Network on MSN4d
Jak Roberto shares update on dream house: 'Ang dami nang nagdaan na pagsubok, wala nang sukuan to!'Jak Roberto's dream house is well under way, and the actor shared the latest developments in a vlog update. In the house tour ...
MedPage Today on MSN5d
Topical JAK Inhibitor Active in Itchy Prurigo NodularisORLANDO -- More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of ...
Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.
Jak Roberto is beaming with excitement as his new home is almost complete, although he admitted that the construction did not ...
As Incyte strives to push its topical JAK inhibitor Opzelura into additional dermatology indications, the company’s latest ...
Kinder had an incredible senior season for the Mustangs, claiming the national record for three point shots made in a high ...
Janus kinase inhibitor cycling may be more effective than switching to bDMARDs among patients with RA who had an inadequate response to initial JAK inhibitor therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback